Drug Pipeline

Setmelanotide Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
1
Recruiting
3
Phase 3
2
Top Sponsors
Active Studies by Phase
Phase 3
3
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06760546 A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of… Hypothalamic Obesity Recruiting
NCT05093634 EMANATE: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R… Obesity Active, Not Recruiting
NCT05774756 A Trial of Setmelanotide in Acquired Hypothalamic Obesity Hypothalamic Obesity Active, Not Recruiting
Phase 2
NCT06772597 A Study of Setmelanotide in Patients With Prader-Willi Syndrome Prader-Willi Syndrome Active, Not Recruiting
NCT07496463 Setmelanotide to Treat Obesity in a Patient With Pseudohypoparathyroidism Type 1a (PHP1a) Pseudohypoparathyroidism Type 1a Not Yet Recruiting
Sponsors Running Setmelanotide Trials
Disease Areas
Get alerts when Setmelanotide trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free